BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32885475)

  • 41. Botulinum toxin in closed treatment of mandibular condylar fracture.
    Canter HI; Kayikcioglu A; Aksu M; Mavili ME
    Ann Plast Surg; 2007 May; 58(5):474-8. PubMed ID: 17452828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.
    Patel AA; Lerner MZ; Blitzer A
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):328-333. PubMed ID: 28290229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obvious morphologic changes in the mandible and condylar cartilage after triple botulinum toxin injections into the bilateral masseter.
    Wang Z; Sa G; Wei Z; Dai X; Wan Q; Yang X
    Am J Orthod Dentofacial Orthop; 2020 Oct; 158(4):e43-e52. PubMed ID: 32988574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of displaced mandibular condylar fracture with botulinum toxin A.
    Akbay E; Cevik C; Damlar I; Altan A
    Auris Nasus Larynx; 2014 Apr; 41(2):219-21. PubMed ID: 24156980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection.
    Grinberg N; Whitefield S; Kleinman S; Frenkel G; Peleg O
    J Oral Maxillofac Surg; 2024 May; 82(5):525-530. PubMed ID: 38438110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compensatory dentoalveolar supraeruption and occlusal plane cant after botulinum-induced hypotrophy of masticatory closing muscles in juvenile rats.
    Choi JW; Kim HJ; Moon JW; Kang SH; Tak HJ; Lee SH
    Arch Oral Biol; 2019 May; 101():34-42. PubMed ID: 30875592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
    Rezazadeh F; Esnaashari N; Azad A; Emad S
    BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Masseter muscle fibre changes following reduction of masticatory function.
    Tsai CY; Lin YC; Su B; Yang LY; Chiu WC
    Int J Oral Maxillofac Surg; 2012 Mar; 41(3):394-9. PubMed ID: 22103999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin.
    Daelen B; Thorwirth V; Koch A
    Int J Oral Maxillofac Surg; 1997 Dec; 26(6):458-60. PubMed ID: 9418151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treating severe bruxism with botulinum toxin.
    Tan EK; Jankovic J
    J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum Toxin Injection to Treat Masticatory Movement Disorder Corrected Mandibular Asymmetry in a Growing Patient.
    Cho YM; Kim SG; Choi DS; Jang I; Cha BK
    J Craniofac Surg; 2019 Sep; 30(6):1850-1854. PubMed ID: 31449215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transition of endochondral bone formation at the normal and botulinum-treated mandibular condyle of growing juvenile rat.
    Tak HJ; Moon JW; Kim JY; Kang SH; Lee SH
    Arch Oral Biol; 2024 Aug; 164():105999. PubMed ID: 38815512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the masseter muscle injection of botulinum toxin A on the mandibular bone growth of developmental rats.
    Seok H; Kim SG; Kim MK; Jang I; Ahn J
    Maxillofac Plast Reconstr Surg; 2018 Dec; 40(1):5. PubMed ID: 29588910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.